Published in Medical Devices and Surgical Technology Week, February 8th, 2004
Under the award, which will support the first year of a potential multi-year biodefense project, Diversa plans to work closely with Agentase, LLC, and Life Science Research Israel, Ltd., (LSRI) to develop an environmentally benign, enzyme-based system that is capable of decontaminating a broad spectrum of both chemical and biological warfare agents. Potential product applications of any successfully developed system include decontaminating sprays, solutions, foams, wound dressings, fabrics, and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.